




Searching News Database: Grupo Ferrer Internacional
HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
HSMN NewsFeed - 19 Oct 2009
AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Additional items found! 3

Members Archive contains
3 additional stories matching:
Grupo Ferrer Internacional
(Password required)
Grupo Ferrer Internacional
(Password required)